RNS - Imaging Biometrics Enters Agreement with MedImageMetric16 Sep 2025 15:54
Imaging Biometrics, LLC (IB), a leading provider of advanced MRI analytics, is pleased to announce an agreement with MedImageMetric, LLC (MIM) to commercialize its patented quantitative susceptibility mapping (QSM) software, QSMetric™. QSMetric is available for immediate sale through IB as an annual license subscription.
"This agreement brings together MIM's innovation and IB's commercialization strength to accelerate access to a powerful, clinically validated imaging solution," said Dr. Yi Wang, PhD, MIM's President. "The fact that QSMetric is both FDA-cleared and patent-protected underscores its scientific rigor and commercial readiness."
The collaboration also opens the door to joint development initiatives, including:
· Integration of QSMetric with IB's solutions to enhance neuro characterization.
· Expansion into multi-parametric imaging workflows for neuro-oncology, neurodegeneration, and vascular disorders.
· Co-development of AI-driven analytics and clinical decision support tools leveraging QSMetric data.
-- BB --